ASTM E 2363 : 2023
Current
The latest, up-to-date edition.
Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry
Hardcopy , PDF
English
23-02-2023
Committee |
E 55
|
DocumentType |
Reference Material
|
Pages |
16
|
PublisherName |
American Society for Testing and Materials
|
Status |
Current
|
Supersedes |
1.1This standard covers terminology used by the E55 Committee relating to pharmaceutical and biopharmaceutical industry for manufacture of pharmaceutical and biopharmaceutical products. Terms that are generally understood and in common usage or adequately defined in other readily available references are not included except where particular delineation to pharmaceutical and biopharmaceutical manufacturing may be more clearly stated.
1.2This terminology is, therefore, intended to be selective of terms used generally in the manufacture of pharmaceutical and biopharmaceutical products and published in a number of documents such as those listed in the succeeding section. The listing is also intended to define terms that appear prominently within other related ASTM International standards and do not appear elsewhere.
1.3The definitions are substantially identical to those published by regulatory agencies such as the U.S. Food and Drug Administration, European Medicines Agency, Pharmaceutical and Medical Devices Agency (Japan), other and national competent authorities (human) as well as other authoritative bodies, such as ICH, ISO, and national standards organizations.
1.4This terminology supplements current documents on terminology that concentrate on the manufacture of pharmaceutical and biopharmaceutical products.
1.5An increasing number of product designations and designations for chemical, physical, mechanical, analytical, and statistical tests and standards are coming into common usage in the literature, regulatory environment, and commerce associated with the manufacture of pharmaceutical and biopharmaceutical products.
1.6Units—The values stated in SI units are to be regarded as the standard. No other units of measurement are included in this standard.
1.7This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.8This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
ASTM E 2891 : 2020 | Standard Guide for Multivariate Data Analysis in Pharmaceutical Development and Manufacturing Applications |
ASTM E 3072 : 2022 : REV A | Standard Terminology for Industrial Biotechnology and Synthetic Biology |
ASTM E 2476 : 2022 | Standard Guide for Risk Assessment and Risk Control as it Impacts the Design, Development, and Operation of PAT Processes for Pharmaceutical Manufacture |
ASTM E 3051 : 2016 | Standard Guide for Specification, Design, Verification, and Application of Single-Use Systems in Pharmaceutical and Biopharmaceutical Manufacturing |
ASTM E 2882 : 2019 | Standard Guide for Analysis of Clandestine Drug Laboratory Evidence |
ASTM E 3326 : 2022 | Standard Guide for Application of Continuous Manufacturing (BioCM) in the Biopharmaceutical Industry |
ASTM E 1732 : 2022 | Standard Terminology Relating to Forensic Science |
ASTM E 2968 : 2023 | Standard Guide for Application of Continuous Manufacturing (CM) in the Pharmaceutical Industry |
ASTM E 2537 : 2016 | Standard Guide for Application of Continuous Process Verification to Pharmaceutical and Biopharmaceutical Manufacturing |
ASTM E 2629 : 2020 | Standard Guide for Verification of Process Analytical Technology (PAT) Enabled Control Systems |
ASTM E 2500 : 2020 | Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment |
ASTM E 2810 : 2019 | Standard Practice for Demonstrating Capability to Comply with the Test for Uniformity of Dosage Units |
ASTM E 3077 : 2017 : EDT 2 | Standard Guide for Raw Material eData Transfer from Material Suppliers to Pharmaceutical & Biopharmaceutical Manufacturers |
ASTM E 2656 : 2016 | Standard Practice for Real-time Release Testing of Pharmaceutical Water for the Total Organic Carbon Attribute |
ASTM E 2500 : 2020 | Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment |
ASTM E 456 : 2013 : REV A : R2022 | Standard Terminology Relating to Quality and Statistics |
ASTM E 456 : 2013 : REV A : R2022 : EDT 1 | Standard Terminology Relating to Quality and Statistics |
ASTM E 1565 : 2000 : R2019 | Standard Guide for Inventory Control and Handling of Biological Material Maintained at Low Temperatures |
ASTM E 1564 : 2000 : R2019 | Standard Guide for Design and Maintenance of Low-Temperature Storage Facilities for Maintaining Cryopreserved Biological Materials |
ASTM E 1566 : 2000 : R2019 | Standard Guide for Handling Hazardous Biological Materials in Liquid Nitrogen |
ASTM E 2629 : 2020 | Standard Guide for Verification of Process Analytical Technology (PAT) Enabled Control Systems |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.